查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587152

臨床試驗影像市場：按產品和服務、模式、治療領域和最終用戶 - 2025-2030 年全球預測

Clinical Trial Imaging Market by Product & Service (Services, Software), Modality (Computed Tomography, Echocardiography, Magnetic Resonance Imaging), Therapeutic area, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年臨床試驗影像市場估值為13.1億美元，預計到2024年將達到13.9億美元，複合年成長率為6.68%，到2030年預計將達到20.6億美元。

臨床試驗影像學是在臨床試驗中使用MRI、 電腦斷層掃描、X光和PET掃描等影像技術來評估新治療方法的有效性和安全性。影像的使用對於可視化治療性介入的生理效果並提供可用於決策流程的客觀、可量化的資料至關重要。臨床試驗中對影像的需求源自於其提供準確和可重複資料的能力。同時，其應用涵蓋腫瘤學、神經學和心臟病學等各個領域，其中先進的成像技術可以分別揭示腫瘤反應、神經系統變化和心臟健康。最終用途相關人員包括製藥公司和委外研發機構(CRO) 以及進行臨床研究的學術機構。顯像模式的技術進步、慢性病盛行率的增加以及臨床試驗數量的快速增加推動了市場成長。此外，基於人工智慧的分析和新成像生物標記的整合代表了一個主要的商機。然而，與先進成像技術相關的高成本、監管複雜性以及多中心臨床實踐中的後勤挑戰可能會阻礙成長。創新機會在於以較低劑量提高影像品質、開發可攜式成像解決方案以及透過人工智慧整合改進資料管理和分析。最佳化影像擷取和解釋通訊協定的研究可以提高資料保真度，從而提高測試結果的穩健性。儘管存在這些機遇，但競爭壓力和某些地區最尖端科技採用緩慢可能會帶來重大挑戰。擴展到臨床試驗影像的公司必須保持技術開發的合作夥伴關係，建立跨學科團隊以提供綜合解決方案，並跟上不斷變化的監管指南，以有效捕捉市場潛力。這是一個充滿活力且充滿挑戰的市場，其特點是快速的技術創新和嚴格的合規要求。

主要市場統計
基準年[2023] 13.1億美元
預測年份 [2024] 13.9億美元
預測年份 [2030] 20.6億美元
複合年成長率（%） 6.68%

市場動態：揭示快速發展的臨床試驗成像市場的關鍵市場洞察

供需的動態交互作用正在改變臨床試驗成像市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 慢性病和癌症的全球流行
    • 透過採用先進的診斷影像技術，越來越重視精準醫療
  • 市場限制因素
    • 成像技術高成本且缺乏相關技術人員
  • 市場機會
    • 整合人工智慧 (AI) 以最大限度地減少錯誤並最大限度地提高效率
    • 增加投資和資金籌措以擴大臨床試驗成像技術
  • 市場挑戰
    • 臨床試驗影像中隱私和同意的倫理問題

波特五力：駕馭臨床試驗影像市場的策略工具

波特的五力架構是了解臨床試驗影像市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解臨床試驗影像市場的外部影響

外部宏觀環境因素在塑造臨床試驗成像市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解臨床試驗影像市場的競爭格局

臨床試驗成像市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣臨床試驗影像市場供應商績效評估

FPNV定位矩陣是評估臨床試驗影像市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了臨床試驗影像市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，臨床試驗成像市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球慢性病和癌症的發生率增加
      • 透過引進先進的影像技術日益重視精準醫療
    • 抑制因素
      • 成像技術高成本且缺乏相關技術人員
    • 機會
      • 人工智慧 (AI) 整合可最大限度地減少錯誤並最大限度地提高效率
      • 增加投資和資金以擴大臨床試驗成像技術
    • 任務
      • 臨床試驗影像中隱私和同意的倫理問題
  • 市場區隔分析
    • 產品與服務：臨床試驗影像服務交付的進展
    • 形態：電腦斷層掃描由於其快速成像功能和詳細的截面影像而越來越受到青睞
    • 治療領域：臨床試驗影像的核心作用及其在不同治療領域不斷發展的應用
    • 最終用戶：學術和政府研究機構對臨床試驗影像的需求不斷增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章臨床試驗影像市場：依產品及服務分類

  • 服務
    • 營運影像服務
    • 閱讀分析服務
    • 系統及技術支援服務
    • 測試設計和諮詢服務
  • 軟體

第7章臨床試驗影像市場：按模式

  • 電腦斷層掃描
  • 心臟超音波圖
  • 磁振造影
  • 正子斷層掃描
  • 超音波
  • X光

第8章依治療領域分類的臨床試驗影像市場

  • 內分泌學
  • 免疫疾病
  • 感染疾病
  • 神經病學
  • 腫瘤學

第9章臨床試驗影像市場：依最終使用者分類

  • 學術和政府研究機構
  • 生技公司
  • 合約調查機構
  • 製藥公司

第10章美洲臨床試驗影像市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太臨床試驗影像市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲臨床試驗影像市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • DeepHealth 與 HOPPR 合作，利用先進的 AI 成像模型徹底改變癌症檢測。
    • Subtle Medical 利用 NIH 資助的人工智慧技術來提高腦部 MRI 的效率，徹底改變了臨床影像。
    • 策略收購GE醫療增強超音波影像精度方面的AI能力
    • Voiant 和 Thirona 之間的策略合作徹底改變了肺部臨床試驗中的人工智慧影像
    • RapidAI進入日本標誌著臨床試驗影像創新的重要里程碑
    • Aidoc 投資 3000 萬美元開發全面的 AI 模型，徹底改變醫學影像準確性
    • Altice Labs 全球舉措利用 AI數位雙胞胎變革癌症臨床試驗設計
    • WCG 與 Mint Medical 合作徹底改變影像工作流程並提高腫瘤臨床試驗中的資料準確性
    • 徹底改變臨床試驗：Clario 推出雲端基礎的影像檢視器，用於即時資料訪問
  • 戰略分析和建議
    • 克拉里奧
    • WCG臨床有限公司
    • 伊西科公司
    • 圖示PLC

公司名單

  • Alimentiv Inc.
  • Anagram 4 Clinical Trials
  • Biospective Inc.
  • Boston Imaging Core Lab LLC
  • Cardiovascular Imaging Technologies LLC
  • Clario
  • GE HealthCare Technologies Inc.
  • Icon PLC
  • Image Core Lab Private Limited
  • Imaging Endpoints II LLC
  • Ixico PLC
  • Median Technologies
  • Medical Metrics Inc. by Catalent, Inc.
  • Medidata by Dassault Systemes
  • Medpace, Inc.
  • Micron Inc.
  • Perceptive Informatics LLC
  • ProScan Imaging LLC
  • Resonance Health Ltd.
  • Voiant Clinical
  • WCG Clinical, Inc.
Product Code: MRR-501246435DF5

The Clinical Trial Imaging Market was valued at USD 1.31 billion in 2023, expected to reach USD 1.39 billion in 2024, and is projected to grow at a CAGR of 6.68%, to USD 2.06 billion by 2030.

Clinical Trial Imaging refers to the use of imaging technology such as MRI, CT scans, X-rays, and PET scans in clinical trials to assess the efficacy and safety of new therapies. The use of imaging is essential for visualizing the physiological effects of therapeutic interventions, providing objective, quantifiable data that can be used in decision-making processes. The necessity of imaging in clinical trials arises from its ability to offer precise and reproducible data, while its applications span various areas, including oncology, neurology, and cardiology, where advanced imaging techniques can reveal tumor response, neurological changes, and cardiac health respectively. End-use stakeholders range from pharmaceutical companies and contract research organizations (CROs) to academic institutions conducting clinical research. Market growth is propelled by technological advancements in imaging modalities, increasing prevalence of chronic diseases, and a surge in the number of clinical trials. Furthermore, AI-driven analysis and the integration of novel imaging biomarkers present significant opportunities. However, high costs associated with advanced imaging technologies, regulatory complexities, and logistical challenges in multicenter trials can hinder growth. Opportunities for innovation lie in enhancing imaging quality at lower doses, developing portable imaging solutions, and improving data management and analysis through AI integration. Research directed towards optimizing image acquisition and interpretation protocols can result in better data fidelity and subsequently, more robust trial outcomes. Despite these opportunities, competitive pressure and the slow adoption of cutting-edge technologies in certain regions can pose significant challenges. Businesses venturing into clinical trial imaging should focus on collaborative partnerships for technology development, building multidisciplinary teams for integrated solutions, and staying abreast of evolving regulatory guidelines to seize market potential effectively. The market is both dynamic and challenging, characterized by rapid technological progress and stringent compliance demands.

KEY MARKET STATISTICS
Base Year [2023] USD 1.31 billion
Estimated Year [2024] USD 1.39 billion
Forecast Year [2030] USD 2.06 billion
CAGR (%) 6.68%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Imaging Market

The Clinical Trial Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic diseases and cancer worldwide
    • Increasing emphasis on precision medicine for the adoption of advanced imaging techniques
  • Market Restraints
    • High cost associated with the imaging techniques and shortage of skilled personnel
  • Market Opportunities
    • Integration of artificial intelligence (AI) to minimize errors and maximize efficiency
    • Increasing investments and funding for the expansion of clinical trial imaging technology
  • Market Challenges
    • Ethical concerns around privacy and consent in clinical trial imaging

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Imaging Market

A detailed market share analysis in the Clinical Trial Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Trial Imaging Market

A strategic analysis of the Clinical Trial Imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Imaging Market, highlighting leading vendors and their innovative profiles. These include Alimentiv Inc., Anagram 4 Clinical Trials, Biospective Inc., Boston Imaging Core Lab LLC, Cardiovascular Imaging Technologies LLC, Clario, GE HealthCare Technologies Inc., Icon PLC, Image Core Lab Private Limited, Imaging Endpoints II LLC, Ixico PLC, Median Technologies, Medical Metrics Inc. by Catalent, Inc., Medidata by Dassault Systemes, Medpace, Inc., Micron Inc., Perceptive Informatics LLC, ProScan Imaging LLC, Resonance Health Ltd., Voiant Clinical, and WCG Clinical, Inc..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Services and Software. The Services is further studied across Operational Imaging Services, Read Analysis Services, System & Technical Support Services, and Trial Design & Consulting Services.
  • Based on Modality, market is studied across Computed Tomography, Echocardiography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, and X-Ray.
  • Based on Therapeutic area, market is studied across Endocrinology, Immunological Disorder, Infectious Diseases, Neurology, and Oncology.
  • Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology Companies, Contract Research Organizations, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic diseases and cancer worldwide
      • 5.1.1.2. Increasing emphasis on precision medicine for the adoption of advanced imaging techniques
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the imaging techniques and shortage of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of artificial intelligence (AI) to minimize errors and maximize efficiency
      • 5.1.3.2. Increasing investments and funding for the expansion of clinical trial imaging technology
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical concerns around privacy and consent in clinical trial imaging
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product & Service: Increasing advancements in clinical trial imaging service offerings
    • 5.2.2. Modality: Growing preference for computed tomography for quick imaging capability and detailed cross-sectional views
    • 5.2.3. Therapeutic area: Pivotal role of clinical trial imaging across diverse therapeutic areas and its evolving applications
    • 5.2.4. End-User: Rising demand of clinical trial imaging in academic & government research institutes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trial Imaging Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Services
    • 6.2.1. Operational Imaging Services
    • 6.2.2. Read Analysis Services
    • 6.2.3. System & Technical Support Services
    • 6.2.4. Trial Design & Consulting Services
  • 6.3. Software

7. Clinical Trial Imaging Market, by Modality

  • 7.1. Introduction
  • 7.2. Computed Tomography
  • 7.3. Echocardiography
  • 7.4. Magnetic Resonance Imaging
  • 7.5. Positron Emission Tomography
  • 7.6. Ultrasound
  • 7.7. X-Ray

8. Clinical Trial Imaging Market, by Therapeutic area

  • 8.1. Introduction
  • 8.2. Endocrinology
  • 8.3. Immunological Disorder
  • 8.4. Infectious Diseases
  • 8.5. Neurology
  • 8.6. Oncology

9. Clinical Trial Imaging Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Government Research Institutes
  • 9.3. Biotechnology Companies
  • 9.4. Contract Research Organizations
  • 9.5. Pharmaceutical Companies

10. Americas Clinical Trial Imaging Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Clinical Trial Imaging Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Trial Imaging Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. DeepHealth partners with HOPPR to revolutionize cancer detection with advanced AI imaging models
    • 13.3.2. Subtle Medical revolutionizes clinical imaging with NIH-funded AI tech for enhanced brain MRI efficiency
    • 13.3.3. GE HealthCare's strategic acquisition to enhance AI capabilities in ultrasound imaging precision
    • 13.3.4. Strategic partnership between Voiant and Thirona to revolutionize AI imaging in pulmonary clinical trials
    • 13.3.5. RapidAI's expansion into Japan marks a significant milestone in clinical trial imaging innovation
    • 13.3.6. Aidoc invests USD 30 million to advance comprehensive AI models revolutionizing precision in medical imaging
    • 13.3.7. Altis Labs' global initiative using AI digital twins to transform cancer clinical trial design
    • 13.3.8. WCG partners with Mint Medical to revolutionize imaging workflows in oncology clinical trials for enhanced data precision
    • 13.3.9. Revolutionizing clinical trials: Clario introduces cloud-based image viewer for real-time data access
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Clario
    • 13.4.2. WCG Clinical, Inc.
    • 13.4.3. Ixico PLC
    • 13.4.4. Icon PLC

Companies Mentioned

  • 1. Alimentiv Inc.
  • 2. Anagram 4 Clinical Trials
  • 3. Biospective Inc.
  • 4. Boston Imaging Core Lab LLC
  • 5. Cardiovascular Imaging Technologies LLC
  • 6. Clario
  • 7. GE HealthCare Technologies Inc.
  • 8. Icon PLC
  • 9. Image Core Lab Private Limited
  • 10. Imaging Endpoints II LLC
  • 11. Ixico PLC
  • 12. Median Technologies
  • 13. Medical Metrics Inc. by Catalent, Inc.
  • 14. Medidata by Dassault Systemes
  • 15. Medpace, Inc.
  • 16. Micron Inc.
  • 17. Perceptive Informatics LLC
  • 18. ProScan Imaging LLC
  • 19. Resonance Health Ltd.
  • 20. Voiant Clinical
  • 21. WCG Clinical, Inc.

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL IMAGING MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL IMAGING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CLINICAL TRIAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CLINICAL TRIAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL IMAGING MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY OPERATIONAL IMAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY READ ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SYSTEM & TECHNICAL SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL DESIGN & CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. CLINICAL TRIAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 243. CLINICAL TRIAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023